Authors:
Rigla, M
Fontcuberta, J
Mateo, J
Caixas, A
Pou, JM
de Leiva, A
Perez, A
Citation: M. Rigla et al., Physical training decreases plasma thrombomodulin in Type I and Type II diabetic patients, DIABETOLOG, 44(6), 2001, pp. 693-699
Authors:
Holm, P
Julier, C
Kockum, I
Senee, V
Blanc, H
Papp, J
Akesson, K
Bartsocas, C
de Leiva, A
Dahlquist, G
Ronningen, KS
Lathrop, M
Luthman, H
Pociot, F
Nerup, J
Citation: P. Holm et al., A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: Identification of new loci with evidence of interactions, AM J HU GEN, 69(6), 2001, pp. 1301-1313
Authors:
Albareda, M
Gallart, L
Mato, ME
Ortiz, A
Puig-Domingo, M
de Leiva, A
Corcoy, R
Citation: M. Albareda et al., Mitochondrial gene transfer ribonucleic acid (tRNA)(Leu(UUR)) 3243 is not a common cause of gestational diabetes mellitus in Spanish women, ENDOCR J, 47(6), 2000, pp. 805-806
Authors:
Rigla, M
Mateo, J
Fontcuberta, J
Souto, JC
de Leiva, A
Perez, A
Citation: M. Rigla et al., Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients, THROMB HAEM, 84(2), 2000, pp. 223-227
Authors:
Corcoy, R
Garcia-Patterson, A
Albareda, M
de Leiva, A
Citation: R. Corcoy et al., Poor performance of American Diabetes Association criteria in women with gestational diabetes, DIABET CARE, 23(3), 2000, pp. 430-431
Authors:
Carreras, G
Mauricio, D
Perez, A
de Leiva, A
Citation: G. Carreras et al., Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?, DIABET CARE, 23(11), 2000, pp. 1715-1716
Authors:
Rigla, M
Sanchez-Quesada, JL
Ordonez-Llanos, J
Prat, T
Caixas, A
Jorba, O
Serra, JR
de Leiva, A
Perez, A
Citation: M. Rigla et al., Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients, METABOLISM, 49(5), 2000, pp. 640-647
Authors:
Albareda, M
Rodriguez-Espinosa, J
Murugo, M
de Leiva, A
Corcoy, R
Citation: M. Albareda et al., Assessment of insulin sensitivity and beta-cell function from measurementsin the fasting state and during an oral glucose tolerance test, DIABETOLOG, 43(12), 2000, pp. 1507-1511
Authors:
Perez, A
Wagner, AM
Carreras, G
Gimenez, G
Sanchez-Quesada, JL
Rigla, M
Gomez-Gerique, JA
Pou, JM
de Leiva, A
Citation: A. Perez et al., Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus - Effect of glycemic control, ARCH IN MED, 160(18), 2000, pp. 2756-2762
Authors:
Larsen, ZM
Kristiansen, OP
Mato, E
Johannesen, J
Puig-Domingo, M
de Leiva, A
Nerup, J
Pociot, F
Citation: Zm. Larsen et al., IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent), AUTOIMMUN, 31(1), 1999, pp. 35-42
Authors:
Chico, A
Perez, A
Cordoba, A
Arcelus, R
Carreras, G
de Leiva, A
Sastre, FG
Blanco-Vaca, F
Citation: A. Chico et al., Is plasma homocysteine related to albumin excretion rate in patients with diabetes mellitus?, DIABETOLOG, 42(3), 1999, pp. 383-383
Authors:
Pinol, C
Guardiola, E
Soler, J
Cano, F
Mijares, AH
Jimenez, A
de Leiva, A
Arroyo, JA
Citation: C. Pinol et al., A double blind, randomised, placebo controlled study to assess the maximuminsulin dose reduction achieved with acarbose in the treatment of insulin-requiring Type 2 diabetic patients, DIABET NUTR, 11(4), 1998, pp. 242-248